Clinical Trial Update: Pharmacological Reduction of Right Ventricular Enlargement [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial testing a pharmacological reduction of right ventricular enlargement has completed in patients with tricuspid regurgitation and right v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Right Ventricular Dilatation
• Tricuspid Regurgitation

Snippet

Sponsor: Asan Medical Center | Conditions: Tricuspid Regurgitation, Right Ventricular Dilatation | Phase 3 | Status: COMPLETED